Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam tosylate vs etomidate for general anesthesia in elderly patients
ChiCTR2100042281Phase 4Recruiting
- Sponsor
- Xiangya Hospital, Central South University
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in anesthesia requirement, postoperative nausea and vomiting (PONV), postoperative delirium (POD) and 1 more (2 arms), sponsored by Xiangya Hospital, Central South University. Primary endpoint: Incidence of postoperative nausea and vomiting. Started Jul 2020; status: recruiting.
02
Drugs
remimazolam
03
Conditions
anesthesia requirementpostoperative nausea and vomiting (PONV)postoperative delirium (POD)sleep disorder
Beyond the preview
Go deeper on ChiCTR2100042281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100042281.